Your Immune System's Unique Signature
A landmark March 2026 study has used machine learning to decode why individuals respond differently to vaccines, paving the way for 'Personalized Vaccination.'
Virtual Patients
Researchers now use AI to create 'virtual patients' that model thousands of immune responses, identifying the best vaccine formulation for specific immune profiles.
Official Insight
The EurekAlert! news release from March 2026 highlights how saliva-based IgA antibodies are key to this personalized approach.
Strategic Data Expansion 2026.4
This data-driven foundation allows for a shift from 'mass vaccination' to 'precision immunization.' By 2026, this technology is being tested to improve vaccine efficacy in immunocompromised individuals, such as those living with HIV.
[Graph comparing immune responses of virtual patients to real-world data]
The goal is to use a simple saliva test to determine the exact 'immune signature' of a patient before recommending a specific vaccination schedule or dose.